Claim OwnershipALPS Speak | Podcast on Psychedelic Science
Subscribed: 8Played: 22
Subscribe
© ALPS (Awareness Lectures in Psychedelic studies)
Description
ALPS Speak (Awareness Lectures in Psychedelic Studies) brings together several outstanding researchers, clinicians and patients working with psychedelic substances.
Its purpose is simple and precise: to give space to subjective, scientific and therapeutic experiences, and raise awareness on Psychedelic-Assisted Therapy (PAT).
Podcast is both in English and French.
More info on http://www.alpsconference.com
Its purpose is simple and precise: to give space to subjective, scientific and therapeutic experiences, and raise awareness on Psychedelic-Assisted Therapy (PAT).
Podcast is both in English and French.
More info on http://www.alpsconference.com
31 Episodes
Reverse
This talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 30.10.2022. More info on the Alps Conference 2022 Website - Twitter - Facebook - Instagram - Youtube
Christopher Timmermann (PhD) has a background in psychology and cognitive neuroscience and is currently a researcher based at Center for Psychedelic Research at Imperial College London. He leads neuroimaging research on potent effects of DMT on the human brain and consciousness, focusing his work on the neuroscience, psychology, ethics and belief systems associated with the psychedelic experience.
More info on Christopher :
Twitter @neurodelia : https://twitter.com/neurodelia
Website : https://scholar.google.com/citations?user=ezYk7h0AAAAJ&hl
Slides from the talk : https://twitter.com/ALPSconference/status/1586671916181585920?s=20&t=4URpcNKdGxHbXJCbqH7r4g
This talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 30.10.2022. More info on the Alps Conference 2022 Website - Twitter - Facebook - Instagram - Youtube
Professor Torsten Passie (MD, PhD) studied philosophy and sociology at Leibniz University Hannover and medicine at Hannover Medical School. Medical dissertation on existential psychiatry. Education at Zürich Psychiatric University Clinic and with Prof. Hanscarl Leuner (1921-1996), the leading European authority on psychedelics and psycholytic therapy. 1997-2010 scientist, psychiatrist and psychotherapist at Hannover Medical School, where he lead the Laboratory for Consciousness and Neurocognition. Professorship thesis about “Psychophysical correlates of altered states of consciousness”. Clinical research on altered states of consciousness, including studies with breathwork, cannabis, MDMA, laughing gas, ketamine and psilocybin. Special expertise on ecstatic states, addictions, and the pharmacology of psychedelics. 2012-2015 Visiting Professor at the Department of Psychiatry of the Harvard Medical School (Boston, USA). Torsten is also the Author of several books, such as “The Science of Microdosing Psychedelics”, “Healing with Entactogens”, and “The Pharmacology of LSD”.
More infomation of Professor Torsten Passie
https://psychedelic-science.org
Dr. Torsten Passie — MDMA, LSD & Psilocybin
Slides of the talks on accessible here : https://twitter.com/ALPSconference/status/1586643240375263232?s=20&t=xXH1NgD5PR92lybl4QGo-Q
This interview was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022. More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Matthias Liechti is a professor of clinical pharmacology and internal medicine at the University Hospital Basel. With his psychopharmacology research team he investigates the pharmacology of psychoactive substances both in vitro and in humans. The team also conducts Pharmaco-fMRI studies and is conducting Phase 2 studies with LSD in patients with cluster headache, major depression, and anxiety disorder in collaboration with the respective disease specialists.
For more information on Mathias :
Website : Matthias Liechti
Universitätsspital Basel
This interview was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022. More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Sam Gandy is a PhD ecologist, independent researcher, consultant and science writer. Sam has varied experience of working within the psychedelic field, as a past scientific assistant to the director of the Beckley Foundation, as a research assistant with the Synthesis Institute, and as a consultant for PsiClone. He is a certified Shinrin Yoku forest bathing practitioner and also leads fungi growing workshops on occasion. He is also collaborating with the Centre for Psychedelic Research at Imperial College London, researching on the capacity of psychedelics to influence human relationships with nature.
More info on Sam :
Twitter : https://twitter.com/SamwiseGandy
Instagram : https://www.instagram.com/samwisegandy
Website : https://www.researchgate.net/profile/Sam-Gandy-4
This interview was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Sam Gandy is a PhD ecologist, independent researcher, consultant and science writer. Sam has varied experience of working within the psychedelic field, as a past scientific assistant to the director of the Beckley Foundation, as a research assistant with the Synthesis Institute, and as a consultant for PsiClone. He is a certified Shinrin Yoku forest bathing practitioner and also leads fungi growing workshops on occasion. He is also collaborating with the Centre for Psychedelic Research at Imperial College London, researching on the capacity of psychedelics to influence human relationships with nature.
More info on Sam :
Twitter : https://twitter.com/SamwiseGandy
Instagram : https://www.instagram.com/samwisegandy
Website : https://www.researchgate.net/profile/Sam-Gandy-4
This talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Kim PC Kuypers is affiliated as an Associate Professor with Maastricht University, Faculty of Psychology and Neuroscience. Her research has three pillars. The main goal is to understand the neurobiology underlying flexible cognition, empathy and well-being. To accomplish this goal she uses a psychopharmacological model, studying the acute, sub-acute, and longer lasting effects of psychedelics on these behaviors and biology. She also conducts survey research to understand the motives underlying psychedelic use and its patterns. Lastly, she develops new paradigms to study cognitive flexibility and empathy in a more ecologically valid way.
For more information on Kim :
Website : https://www.kimkuypers.com
Kim Kuypers (K.P.C.) - Maastricht University
This talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
For over 15 years Dr Ben Sessa has been at the forefront of psychedelic research in the UK through his affiliations with Imperial College London. He has worked for 30 years with patients in the field of addictions and trauma-related psychiatry. Ben has taken part in many psychedelics-related research projects at Bristol University, Cardiff University and Imperial College London, receiving and/or administering these compounds in legal research settings. He is now the Head of Psychedelic Medicine at Awakn Life Sciences, a company opening twenty high street psychedelic medical clinics throughout Europe, providing psychedelic psychotherapy for a wide range of psychiatric indications.
For more information on Ben :
Twitter : https://twitter.com/BenSessa
Website : http://www.drsessa.com
Awakn Life Sciences
This talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022. More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
With a main academic background in Psychology, Helena Aicher has been working in the last years in the Psychedelic Research and Therapy Development team at the UZH. Her research focus is on the neurophysiological and subjective effects of ayahuasca & analogues on therapy-relevant processes.
For more info on Helena :
https://www.dppp.uzh.ch/en/researchgroups/juniorresearchgroups/psychedelic-research-therapy-development.html
https://reconnect-foundation.us19.list-manage.com/subscribe?u=1364c8d642790198e402d60d1&id=d6912cd14b
https://twitter.com/AicherHelena
This interview was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
With a main academic background in Psychology, Helena Aicher has been working in the last years in the Psychedelic Research and Therapy Development team at the UZH. Her research focus is on the neurophysiological and subjective effects of ayahuasca & analogues on therapy-relevant processes.
For more info on Helena :
https://www.dppp.uzh.ch/en/researchgroups/juniorresearchgroups/psychedelic-research-therapy-development.html
https://reconnect-foundation.us19.list-manage.com/subscribe?u=1364c8d642790198e402d60d1&id=d6912cd14b
https://twitter.com/AicherHelena
This discussion was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Professor Torsten Passie (MD, PhD) studied philosophy and sociology at Leibniz University Hannover and medicine at Hannover Medical School. Medical dissertation on existential psychiatry. Education at Zürich Psychiatric University Clinic and with Prof. Hanscarl Leuner (1921-1996), the leading European authority on psychedelics and psycholytic therapy. 1997-2010 scientist, psychiatrist and psychotherapist at Hannover Medical School, where he lead the Laboratory for Consciousness and Neurocognition. Professorship thesis about “Psychophysical correlates of altered states of consciousness”. Clinical research on altered states of consciousness, including studies with breathwork, cannabis, MDMA, laughing gas, ketamine and psilocybin. Special expertise on ecstatic states, addictions, and the pharmacology of psychedelics. 2012-2015 Visiting Professor at the Department of Psychiatry of the Harvard Medical School (Boston, USA). Torsten is also the Author of several books, such as “The Science of Microdosing Psychedelics”, “Healing with Entactogens”, and “The Pharmacology of LSD”.
More infomation of Professor Torsten Passie
https://psychedelic-science.org
Dr. Torsten Passie — MDMA, LSD & Psilocybin
This discussion was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 28.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Rick Doblin is an Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (@MAPS).
More info on Rick :
https://en.wikipedia.org/wiki/Rick_Doblin
https://twitter.com/rickdoblin
Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). He founded MAPS in 1986 and is considered the godfather of the current psychedelic renaissance.
Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.
It’s thanks to his MAPS organization that MDMA is currently at phase 3 trial in the US and will be normally approved by the FDA to treat PTSD patients in 2024.
For more info on Rick Doblin :
MAPS Founder and President
Twitter X : @RickDoblin
TED Talk : the future of psychedelic-assisted psychotherapy
This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.
More info on the Alps Conference 2023 - Website - Twitter - Facebook - Instagram - Youtube
Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC. He and his wife, Annie, completed the first MAPS-sponsored Phase Il clinical trial testing MDMA-assisted psychotherapy for crime-related PTSD, and subsequent studies with military veterans, firefighters and police officers, and a pilot study treating couples. He has been Medical Monitor for a series of Phase 2 trials which produced data that led to FDA breakthrough therapy designation. Since 2012 he and Annie have conducted training for research therapists, and supervision of therapists in two recent, successful Phase 3 clinical trials.
For more info on Michael Mithoefer :
MAPS : https://maps.org/news/media/michael-mithoefer-m-d-principal-investigator/
LinkedIn : https://www.linkedin.com/in/michael-mithoefer-b15bb53b/
This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.
More info on the Alps Conference 2023 - Website - Twitter - Facebook - Instagram - Youtube
Vanja Palmers was born in Austria and grew up in Switzerland. His career as a student at the University of Zürich and as the founder of a successful business start up came to a sudden halt when he ingested a few micrograms of a certain fungi derivative aka LSD. After a few years of being a Hippie and a Yogi, he ended up becoming a Zen person, specializing in being nobody special, making effort towards effortless, traceless praxis…. with mediocre success - Felsentor and Puregg (two meditation centers) as well as some animal rights campaigns and institutions have materialized.
For more info on Vanja Palmers:
Descending the Mountain - a tender film exploring psilocybin and the nature of consciousness
Felsentor Meditation Center in Switzerland
Puregg - Meditation Center in Austria
This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.
More info on the Alps Conference 2023 - Website - Twitter - Facebook - Instagram - Youtube
Abigail Calder is a PhD candidate at the University in Fribourg, Switzerland, where she heads a research project on the effects of LSD on neuroplasticity in healthy people. She also conducts research into the adverse effects of psychedelics and their underlying causes, as well as psychedelics’ effects on people’s values and well-being, and she recently joined the ALPS Foundation as its research coordinator. She completed her Master’s degree in neuroscience at the University of Bonn and holds a Bachelor’s in psychology from TU Dresden.
For more info on Abigail Calder :
Twitter X : @NeuroCalder
LinkedIn : https://www.linkedin.com/in/abigail-calder-bb68831aa/
Fribourg University : https://www.unifr.ch/med/de/section/staff/all/people/323616/a8832
This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.
More info on the Alps Conference 2023 - Website - Twitter - Facebook - Instagram - Youtube
This presentation was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 28.10.2022. More info on the Alps Conference 2021 - Website - Twitter - Facebook - Instagram - Youtube
Dr Peter Sjöstedt-Hughes is a philosopher of mind and metaphysics who specializes in the thought of Spinoza, Nietzsche, and Whitehead, and in fields pertaining to altered and panpsychological states of consciousness. He is a research fellow and associate lecturer at the University of Exeter where he has co-founded the Philosophy of Psychedelics Exeter Research Group.
More info on Peter :
https://www.alpsconference.com/speakers/peter-sjostedt
https://www.philosopher.eu
https://twitter.com/PeterSjostedtH
https://www.ted.com/talks/peter_sjostedt_h_understanding_consciousness_through_psychedelics
This opening talk was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 28.10.2022.
More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Federico Seragnoli is one of the co-founder of the Alps Conference for awareness lectures on psychedelic science.
More information on the Alps on https://www.alpsconference.com and https://www.alps.foundation
This discussion was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 28.10.2022.
More info on the Alps Conference 2021 - Website - Twitter - Facebook - Instagram - Youtube
Dr Peter Sjöstedt-Hughes is a philosopher of mind and metaphysics who specializes in the thought of Spinoza, Nietzsche, and Whitehead, and in fields pertaining to altered and panpsychological states of consciousness. He is a research fellow and associate lecturer at the University of Exeter where he has co-founded the Philosophy of Psychedelics Exeter Research Group.
More info on Peter :
https://www.philosopher.eu
https://twitter.com/PeterSjostedtH
https://www.ted.com/talks/peter_sjostedt_h_understanding_consciousness_through_psychedelics
This discussion was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 28.10.2022. More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube
Recap from Day 1 with Ben and Michael.
This discussion was recorded during the Alps Conference 2021 on psychedelic research in Lausanne, Switzerland on 31.10.2021.
More info on the Alps Conference 2021 - Website - Twitter - Facebook - Instagram - Youtube
We discuss with a worldwide pioneer of psychedelic research, Dr. Franz X. Vollenweider. He is currently Co-Director of the Center for Psychiatric Research and Professor of Psychiatry in the School of Medicine, University of Zurich. He is also the Director of the Heffter Research Center Zürich for Consciousness Studies (HRC-ZH), which he founded in 1998 and incorporated in his research group.
Descending the Mountain - a film exploring psilocybin and the nature of consciousness
For more info on Franz X. Vollenweider's research, check out the Department of Psychiatry at the University of Zurich.
Comments
Download from Google Play
Download from App Store
United States